Search

everythinglearnresearchcommunity

for

Search:↓

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

ONO-3403 effectively reduces mouse skin tumor growth without side effects.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

JAK inhibitors show promise for treating various skin diseases.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

New treatments like JAK inhibitors offer hope for better alopecia areata management.

M1 homeopathic complex may help slow melanoma cell growth.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Imiquimod may be a better non-surgical treatment for cervical pre-cancer, but its effectiveness for vaginal pre-cancer is unclear, and it has some side effects.

CD101 is highly effective in treating dermatophytosis in guinea pigs.

New micelle nanocarriers deliver Tacrolimus more effectively to skin layers for psoriasis treatment than the current Protopic ointment.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.

The document concludes that various topical treatments show promise for skin conditions like atopic dermatitis, psoriasis, and hair loss.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

SB414 may be an effective treatment for atopic dermatitis by reducing swelling and bacterial infection.

A woman's hair loss was likely caused by a cream used for skin treatment and improved after she stopped using it.

The treatment improved survival and controlled cancer spread but required managing side effects like rashes.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.